Papers
1
Total Citations
4
H-Index
1
About
B. R. Asokan is a leading clinical oncologist whose research centers on stereotactic radiosurgery (SRS) for brain metastases, with a particular focus on optimizing treatment outcomes in Indian patient populations. His major contribution lies in the prospective evaluation of SRS as a standalone therapy for oligo-brain metastasis, challenging conventional paradigms that often combine SRS with whole-brain radiotherapy. In his landmark 2023 study, Asokan prospectively analyzed 138 patients with one to five brain metastases, demonstrating that SRS-only treatment yields favorable response rates, survival functions, and recurrence patterns while minimizing toxicity. This work, which has already garnered 4 citations, provides critical real-world evidence from a large Indian cohort—a demographic often underrepresented in neuro-oncology trials. Asokan’s research is notable for its rigorous methodology and patient-centered approach, offering clinicians a toxicity-sparing alternative for managing limited brain metastases. His findings have significant implications for treatment de-escalation strategies, particularly in resource-constrained settings where access to advanced radiotherapy is limited. By establishing safety and efficacy benchmarks for SRS in Indian patients, Asokan is shaping evidence-based practice and improving quality of life for those facing this challenging diagnosis.
Research Focus
Key Achievements
Top Papers
- 1